LIMAA Technologies

LIMAA Technologies specializes in developing a fully automated, tissue-preserving histopathology platform for clinical use. This innovative platform enables the analysis of entire tissue biospecimens in 2D and 3D, without the need for embedding or slicing, preserving the samples for downstream applications. By integrating multiplex biomarker visualization, genomics, and AI-guided decision-making, LIMAA's platform allows pathologists to evaluate tissue samples with cellular 3D spatial resolution, increasing sample throughput and enabling guideline-specific biomarker staining in a clinically feasible time.